Dariush Mozaffarian

Current Institution
Harvard University Medical School
Associate Professor of Medicine and Epidemiology
Division of Cardiovascular Medicine, Department of Epidemiology

Scholar: 2007

Awarded Institution
Harvard University and Harvard School of Public Health


Research Interests

My primary interests are the effects of dietary habits, particularly n-3 and trans fatty acids, on cardiovascular health and disease. As a cardiologist with training in epidemiology and nutrition, I use an integrated approach to formulating research hypotheses and the methods to address these questions. A translational approach also allows application of clinical experiences to research questions and of research results to patient care. To understand more fully the public health and cardiovascular impact of diet, I study effects on multiple cardiovascular outcomes, including coronary heart disease, sudden death, stroke, heart failure, and atrial fibrillation. I am also interested in potential intermediary phenotypes and risk factors, such as heart rate, inflammation, cardiac structure and function, and electrophysiology.

Named Co-Director, Harvard School of Public Health NHLBI T32 National Research Service Award (NRSA) CVD Epi Training Program in Behavior, the Environment, and Global Health.

Invited Member, Expert Consultation on Risks and Benefits of Fish Consumption, World Health Organization / Food and Agriculture Organization of the United Nations.

Invited Member, Expert Consultation on Fats and Fatty Acids in Human Nutrition, World Health Organization / Food and Agriculture Organization of the United Nations.

Invited Member, American Heart Association 2020 Goals Task Force (helping to define the AHA’s overarching goals for the next decade). PI, new NIH/NIEHS ARRA Individual investigator-initiated grant, 3R01 ES014433-03S1, Mercury, Selenium and Risk of Cardiovascular Disease in Women and Men.

PI, new NIH/NHLBI ARRA Individual investigator-initiated grant, RC2 HL101816, Inflammation/ Oxidation, Omega-3's, and Post-Op Atrial Fibrillation and Cognitive Decline.

Co-PI, new Investigator-initiated industry-funded international multi-center phase 3 clinical trial, Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation (OPERA).